Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The Organoids: Global Market Forecast to 2028report has been added to ResearchAndMarkets.com's offering.
The global organoids market is expected to grow from US$ 2.5 billion in 2022 to US$ 8.12 billion by 2028; it is estimated to register a CAGR of 21.8% from 2022 to 2028.
The increasing demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.
Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. The development is likely to introduce new trends in the organoids market during the forecast period.
Application-based Insights
Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.
Source-based Insights
Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2022-2028 |
| Estimated Market Value (USD) in 2022 | $2.5 Billion |
| Forecasted Market Value (USD) by 2028 | $8.12 Billion |
| Compound Annual Growth Rate | 21.8% |
| Regions Covered | Global |
Key Topics Covered
1. Introduction
2. Organoids Market - Key Takeaways
3. Research Methodology
4. Organoids Market - Market Landscape
5. Organoids Market - Key Market Dynamics
6. Organoids Market - Global Analysis
7. Global Organoids Market - Revenue and Forecast to 2028 - By Type
8. Global Organoids Market - Revenue and Forecast to 2028 - By Application
9. Global Organoids Market - Revenue and Forecast to 2028 - By Source
10. Organoids Market - Revenue and Forecast to 2028 - Geographic Analysis
11. Impact of COVID-19 Pandemic on Organoids Market
12. Industry Landscape
13. Company Profiles
14. Appendix
A selection of companies mentioned in this report includes:
- STEMCELL Technologies Inc
- Cellesce Ltd
- Hubrecht Organoid Technology
- Definigen
- Organoid Therapeutics
- PeproTech, Inc
- Thermo Fisher Scientific Inc
- Corning Inc
- Merck KGaA
- InSphero
For more information about this report visit https://www.researchandmarkets.com/r/6n8869
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
